Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer
Más información
| Título según WOS: | Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer |
| Título según SCOPUS: | Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer |
| Título de la Revista: | Breast Cancer Research |
| Volumen: | 13 |
| Número: | 2 |
| Editorial: | Springer Nature |
| Fecha de publicación: | 2011 |
| Idioma: | English |
| URL: | http://breast-cancer-research.com/content/13/2/R21 |
| DOI: |
10.1186/bcr2833 |
| Notas: | ISI, SCOPUS |